Results 311 to 320 of about 297,952 (346)

HPV and HPV Vaccine Awareness: Where Are We?

West Indian Medical Journal, 2014
openaire   +3 more sources

Immediate risk and 5-year cumulative risk of high-grade cervical lesions in high-risk HPV-positive patients with minor cytological abnormalities: a retrospective single-center study in China. [PDF]

BMC Cancer
Kong L, Xiao X, Wan R, Zhao S, Wang W.
europepmc   +1 more source

Human Papillomavirus (HPV) Vaccine Utilization and Its Determinants Among Adolescents in the United Arab Emirates (UAE): A Review. [PDF]

Cureus
Zahid SI, Alnuaimi B, Tamimi K, Zahid NI, Al Saad L, Zahid MI, Muttappallymyalil J, Sreedharan J.   +7 more
europepmc   +1 more source

Temporal changes in prevalence and geographical distribution of human papillomavirus infection in mainland China: a systematic review and analysis of 1.07 million females from 2010 to 2021. [PDF]

BMC Public Health
Chen Q, Wang S, Lin Q, Zhang G.
europepmc   +1 more source

Prevalence, genotype distribution and clearance time of human papillomavirus infection: A retrospective study. [PDF]

Medicine (Baltimore)
Hussein NR, Abozait HJ, Ibrahim NM, Khalid FK, Balatay AA.   +4 more
europepmc   +1 more source

Expanding the case for gender-neutral human papillomavirus vaccination in South Africa: Emerging neonatal and ethical considerations. [PDF]

Afr J Prim Health Care Fam Med
Scheepers VC, Gardner J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HPV and HPV-Associated Diseases

Infectious Disease Clinics of North America, 2013
Human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is associated with a significant burden of disease and cancer, including anogenital warts and recurrent respiratory papillomatosis, and anogenital and oropharyngeal cancers.
Ina U. Park, Eileen F. Dunne
openaire   +3 more sources

Circulating HPV DNA in HPV-associated cancers

Clinica Chimica Acta, 2023
Human papillomavirus (HPV) infections are the primary cause of almost all cervical cancers, anal cancers, and a variable proportion of other anogenital tumors, as well as head and neck cancers. Circulating HPV DNA (cHPV-DNA) is emerging as a biomarker with extensive potential in the management of HPV-driven malignancies.
Guigao Lin, Jinming Li
openaire   +2 more sources